NEWS
See the latest PIR International News, Articles and Network Updates.
Lars Nieba – BioLeader Interview
Chief Executive Officer, Engimmune Therapeutics (June 2023) Lars Nieba serves as CEO of Engimmune Therapeutics, a biotech company developing soluble, multispecific TCRs as therapy for solid tumours and auto-immune diseases. Lars brings more than 25 years of leadership experience [...]
PIR International appoints SVP, Corporate and Commercial Strategy at NMD Pharma
PIR International is pleased to announce the placement of Daniel Brennan as SVP, Corporate and Commercial Strategy at NMD Pharma. NMD Pharma A/S is a clinical-stage biotech company leading in the development of novel first-in-class therapies for severe neuromuscular disorders. [...]
Michael Engsig – BioLeader Interview
Chief Executive Officer, Nykode Therapeutics (May 2023) Michael Engsig joined Nykode Therapeutics in 2017. He is a broadly anchored pharmaceutical professional with extensive experience, from early-stage drug discovery to late-stage development and product launches in biotech and pharma and [...]
Damian Marron – BioLeader Interview
Board Director Cantargia AB, Targovax ASA, CytoSeek, Imophoron, Resolys Bio (May 2023) Damian Marron is an experienced Board Chair and Non-Executive Director, corporate advisor and former serial Biotech CEO with a successful track record of value creation through public [...]